May 26, 2023
Moderately cold temperatures increase longevity and decrease susceptibility to age-related diseases, according to research conducted at the University of Cologne. What to Know Cold temperatures activate a […]
May 22, 2023
Using a microsimulation algorithm that accounts for the effect on mortality, a team from Marseille, France, has shown that interventions targeting the three main vascular risk […]
May 19, 2023
Solriamfetol (Sunosi), a norepinephrine–dopamine reuptake inhibitor, is probably more effective than other wakefulness-promoting medications in patients with obstructive sleep apnea (OSA) who have residual daytime sleepiness […]
May 18, 2023
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has issued new consensus guidance on the assessment and treatment of neurologic sequelae in patients with long […]
May 18, 2023
Physical activity has been tied to a significantly decreased risk of Parkinson’s disease (PD) in women, results of a large, long-term prospective study show. Investigators found […]
May 16, 2023
The US Food and Drug Administration (FDA) has expanded the indication for Abbott Laboratories’ spinal cord stimulation (SCS) devices to include treatment of chronic back pain […]
May 15, 2023
There is a robust link between environmental exposure to the industrial solvent trichloroethylene (TCE) in drinking water and subsequent Parkinson’s disease (PD) in marines attending Marine […]
May 15, 2023
The US Food and Drug Administration (FDA) has approved expanded MRI labeling for Abbott Laboratories’ Eterna spinal cord stimulation (SCS) system, which will allow for higher-quality […]
May 12, 2023
The anti-amyloid agent lecanemab (Leqembi, Eisai) and associated ancillary services could add an estimated $2 to $5 billion annually to Medicare spending, with substantial out-of-pocket costs […]